BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. CRDO
8. OIG
9. AMAT
10. SPY

Go back to BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $99 at RBC Capital

October 26, 2018 7:09 AM EDT

RBC Capital analyst Kennen MacKay raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $99.00 (from $98.00) while maintaining a Sector Perform rating following results.

The analyst notes strong Q3 with top/bottom line beats and tantalizing hints at pipeline updates at the upcoming Nov7 RnD Day.

... More